CYP2B6 Functional Variability in Drug Metabolism and Exposure Across Populations—Implication for Drug Safety, Dosing, and Individualized Therapy
Adverse drug reactions (ADRs) are one of the major causes of morbidity and mortality worldwide. It is well-known that individual genetic make-up is one of the causative factors of ADRs. Approximately 14 million single nucleotide polymorphisms (SNPs) are distributed throughout the entire human genome...
Main Authors: | Immaculate M. Langmia, Katja S. Just, Sabrina Yamoune, Jürgen Brockmöller, Collen Masimirembwa, Julia C. Stingl |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2021.692234/full |
Similar Items
-
Assessment of Substrate Status of Drugs Metabolized by Polymorphic Cytochrome P450 (CYP) 2 Enzymes: An Analysis of a Large-Scale Dataset
by: Jakob Sommer, et al.
Published: (2024-01-01) -
Genetic polymorphisms and drug metabolism
by: Vita Dolžan
Published: (2007-12-01) -
Genetic Polymorphisms in CYP2 Gene Family in Bulgarian Individuals and their Clinical Implications
by: Yovinska S., et al.
Published: (2024-03-01) -
CYP2C19 genetic polymorphism in the Vietnamese population
by: Nhung Phuong Vu, et al.
Published: (2019-08-01) -
African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development
by: Iris Rajman, et al.
Published: (2017-03-01)